Literature DB >> 28660528

Lipid transfers to HDL are diminished in long-term bedridden patients: association with low HDL-cholesterol and increased inflammatory markers.

Wilson Pascoalino Camargo de Oliveira1,2,3, Thauany Martins Tavoni1,2, Fatima Rodrigues Freitas1, Bruna Miranda Oliveira Silva1, Raul Cavalcante Maranhão4,5,6.   

Abstract

Plasma lipids have been extensively studied in sedentary and in subjects practicing exercise training, but not in extreme inactivity as occurs in bedridden patients. This is important for the care of bedridden patients and understanding the overall plasma lipid regulation. Here, we investigated plasma lipids, lipid transfers to HDL and inflammatory markers in bedridden patients. Fasting blood samples were collected from 23 clinically stable bedridden patients under long-term care (>90 days) and 26 normolipidemic sedentary subjects, paired for age and gender. In vitro transfer of four lipids to HDL was performed by incubating plasma with donor nanoparticles containing radioactive lipids. Total (193 ± 36 vs 160 ± 43, p = 0.005), LDL (124 ± 3 vs 96 ± 33 p = 0.003) and HDL-cholesterol (45 ± 10 vs 36 ± 13, p = 0.008), apolipoprotein A-I (134 ± 20 vs 111 ± 24, p = 0.001) and oxidized LDL (53 ± 13 vs 43 ± 12, p = 0.011) were lower in bedridden patients, whereas triglycerides, apolipoprotein B, CETP and LCAT were equal in both groups. Transfers of all lipids, namely unesterified cholesterol, cholesterol esters, triglycerides and phospholipids, to HDL were lower in bedridden patients, probably due to their lower HDL-cholesterol levels. Concentrations of IL-1β, IL-6, IL-8, HGF and NGF were higher in bedridden patients compared to sedentary subjects. In conclusion, inactivity had great impact on HDL, by lowering HDL-cholesterol, apolipoprotein A-I and thereby cholesterol transfers to the lipoprotein, which suggests that inactivity may deteriorate HDL protection beyond the ordinary sedentary condition.

Entities:  

Keywords:  Cholesterol ester transfer protein (CETP); Exercise training; High-density lipoproteins (HDL); Lipid metabolism; Nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 28660528     DOI: 10.1007/s11745-017-4274-x

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  37 in total

Review 1.  High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.

Authors:  Philip Barter; John Kastelein; Alistair Nunn; Richard Hobbs
Journal:  Atherosclerosis       Date:  2003-06       Impact factor: 5.162

Review 2.  Inflammation alters HDL composition and function: implications for HDL-raising therapies.

Authors:  Gunther Marsche; Marcus D Saemann; Akos Heinemann; Michael Holzer
Journal:  Pharmacol Ther       Date:  2012-12-14       Impact factor: 12.310

3.  Lipid transfers to HDL are predictors of precocious clinical coronary heart disease.

Authors:  Raul C Maranhão; Fatima R Freitas; Célia M Strunz; Raul D Santos; Alfredo J Mansur; Antônio P Mansur
Journal:  Clin Chim Acta       Date:  2011-11-19       Impact factor: 3.786

4.  Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol in the metabolic syndrome.

Authors:  Antonio Casella-Filho; Antonio Carlos P Chagas; Raul C Maranhão; Ivani C Trombetta; Fernando H Y Cesena; Vanessa M Silva; Jose Eduardo Tanus-Santos; Carlos E Negrão; Protasio L da Luz
Journal:  Am J Cardiol       Date:  2011-04-15       Impact factor: 2.778

Review 5.  Mechanisms of disease: proatherogenic HDL--an evolving field.

Authors:  Mohamad Navab; Gattadahalli M Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Benjamin J Ansell; Alan M Fogelman
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-09

6.  Elevated circulating levels of the pro-inflammatory cytokine macrophage migration inhibitory factor in individuals with acute spinal cord injury.

Authors:  Matthew Bank; Adam Stein; Cristina Sison; Annemarie Glazer; Navdeep Jassal; Dayna McCarthy; Matthew Shatzer; Barry Hahn; Radhika Chugh; Peter Davies; Ona Bloom
Journal:  Arch Phys Med Rehabil       Date:  2014-11-15       Impact factor: 3.966

Review 7.  Oxidized low-density lipoprotein.

Authors:  Sampath Parthasarathy; Achuthan Raghavamenon; Mahdi Omar Garelnabi; Nalini Santanam
Journal:  Methods Mol Biol       Date:  2010

8.  Sedentary subjects have higher PAI-1 and lipoproteins levels than highly trained athletes.

Authors:  Fabio S Lira; Jose C Rosa; Adriano E Lima-Silva; Hélio A Souza; Erico C Caperuto; Marília C Seelaender; Ana R Damaso; Lila M Oyama; Ronaldo V T Santos
Journal:  Diabetol Metab Syndr       Date:  2010-01-22       Impact factor: 3.320

9.  Enhanced removal from the plasma of LDL-like nanoemulsion cholesteryl ester in trained men compared with sedentary healthy men.

Authors:  Carmen G C Vinagre; Elisabeth S Ficker; Claudia Finazzo; Maria J N Alves; Katia de Angelis; Maria Claudia Irigoyen; Carlos E Negrão; Raul C Maranhão
Journal:  J Appl Physiol (1985)       Date:  2007-07-12

10.  Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy.

Authors:  I-Min Lee; Eric J Shiroma; Felipe Lobelo; Pekka Puska; Steven N Blair; Peter T Katzmarzyk
Journal:  Lancet       Date:  2012-07-21       Impact factor: 79.321

View more
  2 in total

1.  Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma.

Authors:  Cicero P Albuquerque; Fatima R Freitas; Ana Elisa M Martinelli; Josefa H Lima; Rafael F Coelho; Carlos V Serrano; Willian C Nahas; Roberto Kalil Filho; Raul C Maranhão
Journal:  Lipids Health Dis       Date:  2020-06-10       Impact factor: 3.876

2.  Effects of Omega-3 and Antioxidant Cocktail Supplement on Prolonged Bed Rest: Results from Serum Proteome and Sphingolipids Analysis.

Authors:  Pietro Barbacini; Dieter Blottner; Daniele Capitanio; Gabor Trautmann; Katharina Block; Enrica Torretta; Manuela Moriggi; Michele Salanova; Cecilia Gelfi
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.